Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|April 21, 2015
Cardiovascular disease in human immunodeficiency virus-infection as a cause of hospitalization: a case-series in a General Hospital in PeruGermán Valenzuela-Rodríguez, Edward Mezones-Holguín, Fernando Mendo-Urbina, et al.Revista Da Sociedade Brasileira De Medicina Tropical|November 22, 2017
Infective endocarditis due to Bartonella bacilliformis associated with systemic vasculitis: a case reportJoshua Peñafiel-Sam, Samuel Alarcón-Guevara, Sergio Chang-Cabanillas, et al.Revista Peruana De Medicina Experimental Y Salud Publica|August 29, 2019
[Ceftriaxone-resistant Streptococcus pneumoniae meningitis: case report]Marcos Saavedra-Velasco, Mariel Tapia-Cruz, J Antonio Grandez-Urbina, et al.Thorax|January 13, 2023
Faster lung function decline in people living with HIV despite adequate treatment: a longitudinal matched cohort studyRebekka Faber Thudium, Andreas Ronit, Shoaib Afzal, et al.Revista Chilena De Infectologia : Organo Oficial De La Sociedad Chilena De Infectologia|December 21, 2019
[Antimicrobial Stewardship programs in Peru: A fundamental agreement]Cristhian Hernández-Gómez, Luis Hercilla, Fernando Mendo, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|August 4, 2009
Sustained antiretroviral effect of raltegravir after 96 weeks of combination therapy in treatment-naive patients with HIV-1 infectionMartin Markowitz, Bach-Yen Nguyen, Eduardo Gotuzzo, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|August 28, 2007
Rapid and durable antiretroviral effect of the HIV-1 Integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection: results of a 48-week controlled studyMartin Markowitz, Bach-Yen Nguyen, Eduardo Gotuzzo, et al.Infectious Diseases and Therapy|September 26, 2023
Week 240 Efficacy and Safety of Fostemsavir Plus Optimized Background Therapy in Heavily Treatment-Experienced Adults with HIV-1Judith A Aberg, Bronagh Shepherd, Marcia Wang, et al.Antimicrobial Agents and Chemotherapy|May 3, 2022
Week 96 Genotypic and Phenotypic Results of the Fostemsavir Phase 3 BRIGHTE Study in Heavily Treatment-Experienced Adults Living with Multidrug-Resistant HIV-1Margaret Gartland, Pedro Cahn, Edwin DeJesus, et al.Pageof 1